Medmira Inc. Stock
Your prediction
Pros and Cons of Medmira Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medmira Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medmira Inc. | 0.000% | 0.000% | -8.000% | -59.649% | -8.000% | -56.329% | - |
| Theralase Technologies Inc | 0.690% | 2.837% | 64.773% | -14.706% | 64.773% | -35.841% | 9.848% |
| Atossa Genetics Inc | -5.220% | -12.269% | -12.107% | -42.711% | -12.107% | -36.123% | -73.830% |
| Mauna Kea Tech | -11.100% | -6.143% | 131.338% | -15.769% | 131.338% | -69.009% | -91.757% |
News
Health Canada approves MedMira’s Reveal® Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal®
